QHSLab, Inc. - 10-Q Filing

QHSLab, Inc. reports Q3 2026 financial results including revenue streams from allergy diagnostic kits and immunotherapy treatments.

SEC EDGAR ·

Tickers: $USAQ

Read the full article at SEC EDGAR

More Regulatory news